BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24898045)

  • 1. IL36RN mutation causing generalized pustular psoriasis in a Palestinian patient.
    Renert-Yuval Y; Horev L; Babay S; Tams S; Ramot Y; Zlotogorski A; Molho-Pessach V
    Int J Dermatol; 2014 Jul; 53(7):866-8. PubMed ID: 24898045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis.
    Kanazawa N; Nakamura T; Mikita N; Furukawa F
    J Dermatol; 2013 Sep; 40(9):749-51. PubMed ID: 23834760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized pustular psoriasis in a 92-year-old man with a homozygous nonsense mutation in IL36RN.
    Ueda Y; Komine M; Kamiya K; Tsuda H; Maekawa T; Murata S; Ohtsuki M
    J Dermatol; 2018 Mar; 45(3):326-328. PubMed ID: 29215143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.
    Tauber M; Bal E; Pei XY; Madrange M; Khelil A; Sahel H; Zenati A; Makrelouf M; Boubridaa K; Chiali A; Smahi N; Otsmane F; Bouajar B; Marrakchi S; Turki H; Bourrat E; Viguier M; Hamel Y; Bachelez H; Smahi A
    J Invest Dermatol; 2016 Sep; 136(9):1811-1819. PubMed ID: 27220475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis.
    Sugiura K; Takeichi T; Kono M; Ogawa Y; Shimoyama Y; Muro Y; Akiyama M
    Br J Dermatol; 2012 Sep; 167(3):699-701. PubMed ID: 22428995
    [No Abstract]   [Full Text] [Related]  

  • 6. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.
    Rossi-Semerano L; Piram M; Chiaverini C; De Ricaud D; Smahi A; Koné-Paut I
    Pediatrics; 2013 Oct; 132(4):e1043-7. PubMed ID: 24019411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
    Shibata A; Sugiura K; Furuta Y; Mukumoto Y; Kaminuma O; Akiyama M
    J Autoimmun; 2017 Jun; 80():28-38. PubMed ID: 28196704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
    Abbas O; Itani S; Ghosn S; Kibbi AG; Fidawi G; Farooq M; Shimomura Y; Kurban M
    Dermatology; 2013; 226(1):28-31. PubMed ID: 23428889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute generalized exanthematous pustulosis caused by dihydrocodeine phosphate in a patient with psoriasis vulgaris and a heterozygous IL36RN mutation.
    Nakai N; Sugiura K; Akiyama M; Katoh N
    JAMA Dermatol; 2015 Mar; 151(3):311-5. PubMed ID: 25409173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoinflammatory diseases in dermatology: DITRA and CAMPS].
    Sugiura K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):169-173. PubMed ID: 28747603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.
    Okorie CL; Nayudu K; Nambudiri VE
    Exp Dermatol; 2024 Jan; 33(1):e14934. PubMed ID: 37726967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
    Ho PH; Tsai TF
    J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases.
    Yoshikawa M; Rokunohe D; Kimura A; Takahashi M; Korekawa A; Nakajima K; Nakano H; Yokoyama M; Tanaka K; Yokoyama Y; Sawamura D
    J Dermatol; 2021 May; 48(5):699-702. PubMed ID: 33599999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
    Sugiura K
    J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
    Arakawa A; Ruzicka T; Prinz JC
    JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
    Zhu T; Jin H; Shu D; Li F; Wu C
    Eur J Dermatol; 2018 Apr; 28(2):217-224. PubMed ID: 29619998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation of IL36RN.
    Koike Y; Okubo M; Kiyohara T; Fukuchi R; Sato Y; Kuwatsuka S; Takeichi T; Akiyama M; Sugiura K; Utani A
    Br J Dermatol; 2017 Dec; 177(6):1732-1736. PubMed ID: 28369922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous IL36RN mutation and NSD1 duplication in a patient with severe pustular psoriasis and symptoms unrelated to deficiency of interleukin-36 receptor antagonist.
    Carapito R; Isidor B; Guerouaz N; Untrau M; Radosavljevic M; Launay E; Cassagnau E; Frenard C; Aubert H; Romefort B; Le Caignec C; Ott L; Paul N; Barbarot S; Bahram S
    Br J Dermatol; 2015 Jan; 172(1):302-5. PubMed ID: 25039711
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.
    Farooq M; Nakai H; Fujimoto A; Fujikawa H; Matsuyama A; Kariya N; Aizawa A; Fujiwara H; Ito M; Shimomura Y
    Hum Mutat; 2013 Jan; 34(1):176-83. PubMed ID: 22903787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella zoster virus-associated generalized pustular psoriasis in a baby with heterozygous IL36RN mutation.
    Sugiura K; Uchiyama R; Okuyama R; Akiyama M
    J Am Acad Dermatol; 2014 Nov; 71(5):e216-8. PubMed ID: 25438000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.